Arcadia Biosciences (RKDA) Reports Q4 Revenues Above Estimates

Arcadia Biosciences (NASDAQ: RKDA) reported Q4 revenue for the quarter came in at $1.43 million versus the consensus estimate of $800 thousand.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• FactSet (FDS) Tops Q3 EPS by 8c ; Offers Guidance
• Evercore ISI Upgrades Werner Enterprises (WERN) to In Line
• Baird Reiterates Outperform Rating on Nike (NKE)